VION PHARMACEUTICALS INC
Vion Pharmaceuticals, Inc. is a biopharmaceutical company that discovers, develops, and commercializes cancer treatment technologies.
VION PHARMACEUTICALS INC
Industry:
Biopharma Biotechnology Health Care Oncology Pharmaceutical
Founded:
1992-03-27
Address:
New Haven, Connecticut, United States
Country:
United States
Website Url:
http://www.vionpharm.com
Total Employee:
10001+
Status:
Active
Contact:
1-203-498-4210
Similar Organizations
Agios Pharmaceuticals
Agios Pharmaceuticals is a biopharmaceutical company discovers and develops therapeutics in the field of cancer metabolism.
Arctic Therapeutics
Arctic Therapeutics (AT) uses bioinformatic approaches and AI to eliminate major risks associated with traditional drug development.
Arcus Biosciences
Arcus Biosciences is a biopharmaceutical company that discovers, develops, and commercializes novel therapies for the treatment of cancer.
Gilead Sciences
Gilead Sciences is a biopharmaceutical company that discovers, develops, manufactures and commercializes therapies for critical diseases.
Longevity Biotech
Longevity Biotech develops a new class of therapeutics via artificial protein technology that focuses on pharmaceutical preparation.
NephroDI Therapeutics
NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney.
New Century Pharmaceuticals
New Century Pharmaceuticals, Inc. is a biopharmaceutical company with an Oncology and Anti-infective focus which uses leading expertise.
Halo Labs
Halo Labs is a biotechnology company that specializes in analytical instrumentation and biopharma.
Pinpoint Therapeutics
Pinpoint Therapeutics is a preclinical stage company developing novel cancer treatment options aimed to specifically inhibit autophagy.
Official Site Inspections
http://www.vionpharm.com
- Host name: 172.67.153.16
- IP address: 172.67.153.16
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Vion Pharmaceuticals Inc"
Vion Pharmaceuticals | Vion Pharma | Home
Vion Pharmaceuticals, Inc. is developing novel agents for the treatment of cancer. We have two small molecule anticancer compounds under evaluation in human clinical trials.See details»
About Vion - Vion Pharmaceuticals, Inc.
We are committed to extending the lives and improving the quality of life of cancer patients worldwide by bringing innovative cancer treatments to market. Incorporated in March 1992 to โฆSee details»
Vion Pharmaceuticals, Inc. | Corporate Governance
Code of Ethics Code of Ethics for CEO and Senior Financial Officials Code of Ethics and Conduct for Directors, Officers and Employees Committee Charters Nominating and Governance โฆSee details»
Vion Pharmaceuticals Inc - Crunchbase Company โฆ
Vion Pharmaceuticals, Inc. is a biopharmaceutical company that discovers, develops, and commercializes cancer treatment technologies. View contacts โฆSee details»
Vion Pharmaceuticals, Inc. | Insights
Mar 7, 2012ย ยท Karl Schwartz, who previously served as a patient representative to the US Food and Drug Administration's Oncologic Drugs Advisory Committee, is calling on the agency to โฆSee details»
Vion Pharmaceuticals Holds Annual Meeting And Provides
Oct 25, 2005ย ยท Slides being presented at the meeting will be available on the Companyโs website (http://www.vionpharm.com) at 10:00 A.M. Eastern Time. Summary of New Developments. โฆSee details»
Vion Pharmaceuticals, Inc. - Drug pipelines, Patents ... - Patsnap
Explore Vion Pharmaceuticals, Inc. with its drug pipeline, therapeutic area, technology platform, 24 clinical trials, 4 news, and 117 literature, Drug:ORX-103, OCX-0177, Porfiromycin, OCX โฆSee details»
Vion Pharmaceuticals, Inc. | Working at Vion
Vion Pharmaceuticals, Inc. is a pharmaceutical company engaged in the development and commercialization of therapeutics for the treatment of cancer. We are excited about our future, โฆSee details»
Vion Pharmaceuticals Adds William Hahne, M.D. to Senior
Feb 4, 2008ย ยท Triapine(R), a potent inhibitor of a key step in DNA synthesis, is being evaluated in clinical trials sponsored by the National Cancer Institute. For additional information on Vion โฆSee details»
VION and Yale University present preclinical | EurekAlert!
NEW HAVEN, CT -- APRIL 6, 2000 -- VION PHARMACEUTICALS, INC. (NASDAQ NM: VION) and Yale University presented preclinical data on a new anticancer agent (VNP40101M) of the โฆSee details»
What is Vion Pharmaceuticals? Company Culture, Mission, Values
See what employees say it's like to work at Vion Pharmaceuticals. Salaries, reviews, and more - all posted by employees working at Vion Pharmaceuticals.See details»
Officers - Vion Pharmaceuticals, Inc.
Mr. Kessman was appointed the Chief Executive Officer and President in 1999. His prior management experience has been primarily in the telecommunications and healthcare โฆSee details»
Vion Pharmaceuticals Files for Chapter 11 Bankruptcy
Dec 18, 2009ย ยท For additional information on Vion and its product development programs, visit the Company's Internet web site at www.vionpharm.com.See details»
Vion Pharma - Facebook
Vion Pharma. 1,254 likes. Our purpose to champion everyone's right to be happy and healthy. Also to be the first choice for Ph.See details»
Working at Vion Pharmaceuticals - Glassdoor
See what employees say it's like to work at Vion Pharmaceuticals. Salaries, reviews, and more - all posted by employees working at Vion Pharmaceuticals.See details»
Investor Relations - Vion Pharmaceuticals, Inc.
Our management and staff are dedicated to one purpose: developing therapeutic drugs for cancer. Follow the links to learn more about our company and our people, to read our latest โฆSee details»
Vion Pharmaceuticals, Inc. (Vion Pharmaceuticals, Inc.) - ่ฏ็ฉ็ฎก็บฟ_ โฆ
RATIONALE: Drugs used in chemotherapy, such as temozolomide and VNP40101M, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them โฆSee details»
Vion Pharmaceuticals Holds Annual Meeting And Provides
Oct 25, 2005ย ยท The Annual Meeting will be held today at 10:00 A.M. Eastern Time at The Kitano Hotel, 66 Park Avenue, New York, NY 10016. Slides being presented at the meeting will be โฆSee details»
Comprehensive Cancer Information - NCI
NCI has 30 divisions, offices, and centers who work together to build, maintain, and enhance a cohesive and comprehensive cancer research agenda. NCI relies on advisory committees to โฆSee details»
Vion Pharmaceuticals, Inc. | Board of Directors
Name Position Background; William R. Miller: Chairman of the Board * Chairman of the Board of MedaSorb Technologies * Former Director of ImClone Systems, Inc.See details»